An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread
Clinical trial NCT02658890 · COMPLETED
Trial details
- NCT number
- NCT02658890
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-14
- Primary completion
- 2021-10-26
- Enrollment
- 627
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.